You are here

Article Text

Article menu
Download PDFPDF
Case reports
Primary human parvovirus B19 infection in an HIV infected patient on highly active antiretroviral therapy
  1. J Clarke1,
  2. J D Lee2
  1. 1Department of Genitourinary Medicine, Centre for Sexual Health, Sunnybank Wing, Leeds General Infirmary, Great George Street, Leeds LS1 3EX, UK
  2. 2Department of Genitourinary Medicine, Mid-Yorkshire Hospitals Trust, Clayton Hospital, Wakefield WF1 3JS, UK
  1. Correspondence to:
    Dr J Clarke, Department of Genitourinary Medicine, Centre for Sexual Health, Sunnybank Wing, Leeds General Infirmary, Great George Street, Leeds LS1 3EX, UK;
    Jan.clarke{at}leedsth.nhs.uk

Abstract

Adults developing primary human parvovirus B19 (B19) infection may present with arthralgia, fever, and maculopapular rash. Recovery is linked to the development of specific neutralising antibodies. In immunosuppressed patients, including those with HIV infection, such humoral responses are impaired and severe chronic bone marrow suppression and arthritis may occur.

  • human parvovirus B19
  • HIV infection
  • HAART

https://doi.org/10.1136/sti.79.4.336

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text